ALPHA TRIBE

Anthem Biosciences LimitedBoard Meeting, 21-07-2026: Outcome of Board Meeting

21-07-2026 | 04:26 pm

Anthem Biosciences' board approved the Q1 financial results. Consolidated revenue from operations stood at ₹418.22 Cr, with a net profit of ₹119.94 Cr. The company also allotted 1.67 million shares under its ESOP scheme.

No comments yet. Be the first to comment!

All announcements from Anthem Biosciences Limited